Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1731516

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1731516

Lactase Market Growth, Size, Trends Analysis - By Source, By Application, By Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

PUBLISHED:
PAGES: 256 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Lactase Market Introduction and Overview

According to SPER market research, 'Global Lactase Market Size- By Source, By Application, By Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Lactase Market is predicted to reach 403.58 million by 2034 with a CAGR of 5.33%.

Lactase is an enzyme present in the stomachs of humans and other animals that splits lactose into glucose and galactose. Lactose is found in milk products, and lactase aids in its breakdown. Some populations are unable to digest the lactose found in milk products due to a lack of lactase enzymes. To address this issue, lactase is added to dairy products or lactase supplements are supplied so that lactose can be broken down before to intake.

Restraints: Many people are lactose intolerant, which prevents them from drinking milk and dairy products. Lactose-free milk is available, however it is more expensive than regular milk. There have been several ways studied for lowering lactose in milk and dairy products. Lactose-free products are more expensive because the lactose hydrolysis process adds costs. Small and medium-sized enterprises can efficiently manage costs despite a lack of resources and capital, as well as implementation experience.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Source, By Application, By Form.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Mitushi Biopharma, Rajvi Enterprise, Infinita Biotech Private Limited, Aumgene Biosciences, DuPont, Antozyme Biotech Pvt Ltd, Novact Corporation, Biolaxi Corporation, Creative Enzymes, Nature BioScience Pvt. L.T.D, ENMEX, Advanced Enzyme Technologies, Amano Enzyme Inc, Senson, Merck KGaA.

Lactase Market Segmentation:

By Source: Based on the Source, Global Lactase Market is segmented as; Fungi, Yeast, Bacteria.

By Application: Based on the Application, Global Lactase Market is segmented as; Food & Beverages, Dietary Supplements, Pharmaceuticals.

By Form: Based on the Form, Global Lactase Market is segmented as; Powder, Liquid.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Product Code: FOOD2548

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Lactase Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Lactase Market

7. Global Lactase Market, By Source (USD Million) 2021-2034

  • 7.1. Fungi
  • 7.2. Yeast
  • 7.3. Bacteria

8. Global Lactase Market, By Application (USD Million) 2021-2034

  • 8.1. Food & Beverages
    • 8.1.1. Milk
    • 8.1.2. Cheese
    • 8.1.3. Yogurt
    • 8.1.4. Others
  • 8.2. Dietary Supplements
  • 8.3. Pharmaceuticals

9. Global Lactase Market, By Form (USD Million) 2021-2034

  • 9.1. Powder
  • 9.2. Liquid

10. Global Lactase Market, (USD Million) 2021-2034

  • 10.1. Global Lactase Market Size and Market Share

11. Global Lactase Market, By Region, (USD Million) 2021-2034

  • 11.1. Asia-Pacific
    • 11.1.1. Australia
    • 11.1.2. China
    • 11.1.3. India
    • 11.1.4. Japan
    • 11.1.5. South Korea
    • 11.1.6. Rest of Asia-Pacific
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. United Kingdom
    • 11.2.6. Rest of Europe
  • 11.3. Middle East and Africa
    • 11.3.1. Kingdom of Saudi Arabia
    • 11.3.2. United Arab Emirates
    • 11.3.3. Qatar
    • 11.3.4. South Africa
    • 11.3.5. Egypt
    • 11.3.6. Morocco
    • 11.3.7. Nigeria
    • 11.3.8. Rest of Middle-East and Africa
  • 11.4. North America
    • 11.4.1. Canada
    • 11.4.2. Mexico
    • 11.4.3. United States
  • 11.5. Latin America
    • 11.5.1. Argentina
    • 11.5.2. Brazil
    • 11.5.3. Rest of Latin America

12. Company Profile

  • 12.1. Mitushi Biopharma
    • 12.1.1. Company details
    • 12.1.2. Financial outlook
    • 12.1.3. Product summary
    • 12.1.4. Recent developments
  • 12.2. Rajvi Enterprise
    • 12.2.1. Company details
    • 12.2.2. Financial outlook
    • 12.2.3. Product summary
    • 12.2.4. Recent developments
  • 12.3. Infinita Biotech Pvt. Ltd
    • 12.3.1. Company details
    • 12.3.2. Financial outlook
    • 12.3.3. Product summary
    • 12.3.4. Recent developments
  • 12.4. Aumgene Biosciences
    • 12.4.1. Company details
    • 12.4.2. Financial outlook
    • 12.4.3. Product summary
    • 12.4.4. Recent developments
  • 12.5. DuPont
    • 12.5.1. Company details
    • 12.5.2. Financial outlook
    • 12.5.3. Product summary
    • 12.5.4. Recent developments
  • 12.6. Antozyme Biotech Pvt. Ltd
    • 12.6.1. Company details
    • 12.6.2. Financial outlook
    • 12.6.3. Product summary
    • 12.6.4. Recent developments
  • 12.7. Novact Corp
    • 12.7.1. Company details
    • 12.7.2. Financial outlook
    • 12.7.3. Product summary
    • 12.7.4. Recent developments
  • 12.8. Biolaxi Corp
    • 12.8.1. Company details
    • 12.8.2. Financial outlook
    • 12.8.3. Product summary
    • 12.8.4. Recent developments
  • 12.9. Creative Enzymes
    • 12.9.1. Company details
    • 12.9.2. Financial outlook
    • 12.9.3. Product summary
    • 12.9.4. Recent developments
  • 12.10. Nature BioScience Pvt. Ltd
    • 12.10.1. Company details
    • 12.10.2. Financial outlook
    • 12.10.3. Product summary
    • 12.10.4. Recent developments
  • 12.11. ENMEX
    • 12.11.1. Company details
    • 12.11.2. Financial outlook
    • 12.11.3. Product summary
    • 12.11.4. Recent developments
  • 12.12. Advanced Enzyme Technologies
    • 12.12.1. Company details
    • 12.12.2. Financial outlook
    • 12.12.3. Product summary
    • 12.12.4. Recent developments
  • 12.13. Amano Enzyme Inc
    • 12.13.1. Company details
    • 12.13.2. Financial outlook
    • 12.13.3. Product summary
    • 12.13.4. Recent developments
  • 12.14. Senson
    • 12.14.1. Company details
    • 12.14.2. Financial outlook
    • 12.14.3. Product summary
    • 12.14.4. Recent developments
  • 12.15. Merck KGaA
    • 12.15.1. Company details
    • 12.15.2. Financial outlook
    • 12.15.3. Product summary
    • 12.15.4. Recent developments
  • 12.16. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!